Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
activity values by a factor of 2 smaller and by a factor 2.5 higher, respectively, than ICRP 67.<br />
At 10,000 days post <strong>in</strong>take the amount of activity <strong>in</strong> the blood compartment doesn’t<br />
significantly differ <strong>in</strong> relation to the adopted skeletal model. On the basis of such<br />
considerations it can be concluded that, by predict<strong>in</strong>g greater amounts of <strong>Plutonium</strong> <strong>in</strong> the<br />
transfer compartment at <strong>in</strong>termediate and long time, Polig’s model seems to be able to correct<br />
the low ur<strong>in</strong>ary excretion of <strong>Plutonium</strong> calculated with the ICRP 67 model when no transfer<br />
of activity from ST0 soft tissue compartment to ur<strong>in</strong>ary bladder content is assumed (ICRP67a<br />
curve <strong>in</strong> Figure 3.1.4). This can be verified by substitut<strong>in</strong>g the ICRP skeletal model <strong>in</strong> the<br />
ICRP67-a version with Polig’s skeletal model and then calculat<strong>in</strong>g the ur<strong>in</strong>ary excretion of<br />
<strong>Plutonium</strong> (ICRP67-a-Polig curve <strong>in</strong> Figure 3.1.11).<br />
Fraction of <strong>in</strong>itial activity<br />
1E+1<br />
1E+0<br />
1E-1<br />
1E-2<br />
1E-3<br />
1 10 100 1000 10000 100000<br />
Days post <strong>in</strong>take<br />
Figure 3.1.10 Fraction of <strong>in</strong>itial activity reta<strong>in</strong>ed <strong>in</strong> blood and skeleton for a study model<br />
composed by a blood compartment connected to a skeletal model (ICRP 67 or<br />
Polig’s skeletal model).<br />
As expected from Figure 3.1.8 the substitution of the skeletal model doesn’t<br />
significantly affect the activity <strong>in</strong> blood compartment up to 100 days post <strong>in</strong>jection and<br />
therefore doesn’t modify the ur<strong>in</strong>ary excretion <strong>in</strong> this time range. At long time the <strong>in</strong>crease of<br />
available activity <strong>in</strong> blood compartment follow<strong>in</strong>g the <strong>in</strong>troduction of Polig’s skeletal model<br />
(observed <strong>in</strong> Figure 3.1.10) enhances the ur<strong>in</strong>ary excretion of <strong>Plutonium</strong>: In Figure 3.1.11 the<br />
ur<strong>in</strong>ary excretion is closer to the reference data set up to about 2,000 days post <strong>in</strong>jection. In<br />
this time range Polig’s skeletal model has effected a lift of the excretion curve by a factor 2.5<br />
<strong>in</strong> comparison with the excretion of ICRP67-a model. This seems to support the claim that<br />
Polig’s skeletal model is a more realistic description of <strong>Plutonium</strong> biok<strong>in</strong>etics <strong>in</strong> skeleton than<br />
the skeletal model adopted <strong>in</strong> ICRP 67. After 2,000 days post <strong>in</strong>jection the model predictions<br />
underestimate the reference data set. For example at 10,000 days the model calculations are<br />
low by nearly a factor of two, if compared to ICRP 67 (0.0011%/d -1 ), Khokhryakov<br />
(0.0011%/d -1 ) and Langham’s subject HP-6 (0.0014%/d -1 ).<br />
100<br />
ICRP67: blood compartment<br />
ICRP67: skeleton<br />
Polig: blood compartment<br />
Polig: skeleton